Role of NC2β Protein in Neuroblastoma
Author Information
Author(s): Di Pietro Cinzia, Ragusa Marco, Barbagallo Davide, Duro Laura R, Guglielmino Maria R, Majorana Alessandra, Giunta Veronica, Rapisarda Antonella, Tricarichi Elisa, Miceli Marco, Angelica Rosario, Grillo Agata, Banelli Barbara, Defferari Isabella, Forte Stefano, Laganà Alessandro, Bosco Camillo, Giugno Rosalba, Pulvirenti Alfredo, Ferro Alfredo, Grzeschik Karl H, Di Cataldo Andrea, Tonini Gian P, Romani Massimo, Purrello Michele
Primary Institution: Università di Catania
Hypothesis
The involvement of GTA protein NC2β in Neuroblastoma pathogenesis suggests that it physiologically participates in the regulation of cell proliferation.
Conclusion
NC2β is specifically involved in Neuroblastoma pathogenesis and may serve as a new biomarker for the disease.
Supporting Evidence
- 74% of Neuroblastoma samples showed reduced levels of NC2β mRNA.
- Significant correlation between NC2β transcript reduction and advanced stages of Neuroblastoma.
- Genomic deletions at the NC2β locus were found in most samples with low NC2β mRNA levels.
Takeaway
Researchers found that a protein called NC2β is often lower in children with Neuroblastoma, which might help doctors understand and treat this cancer better.
Methodology
RT-PCR was used to analyze mRNA levels in 58 Neuroblastoma biopsies.
Participant Demographics
30 males and 28 females, with various tumor primary sites.
Statistical Information
P-Value
0.0039
Statistical Significance
p = 0.0039
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website